ADI-001
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ADI-001, covering 2025-06-18 to 2025-12-08. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1 Study of ADI-001 in Rheumatoid Arthritis [Phase 1]